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Case Report
A 41-year-old woman, previously treated for an intracra-
nial ependymoma fourteen years earlier, presented with the 
onset of  new headaches. She originally presented in 1992 
with complaints of  right sided headaches; and radiologic 
evaluation identified a multi-cystic lesion with regions of  
contrast enhancement in the left posterior parietal region 
concerning for astrocytoma. After subtotal resection, patho-
logic evaluation revealed malignant ependymoma with 
grossly positive margins. Post-operative MRI showed the 
resection cavity without evidence of  gross residual disease. 
She accepted adjuvant radiation and received fractionated 
stereotactic radiosurgery with 2700 cGy in six fractions 
(450 cGy per fraction) to the clinical target volume, fol-
lowed by 4000 cGy to the brain in twenty fractions (by a 
wedged pair) with a 600 cGy boost to a reduced volume in 
three fractions. Treatments were delivered with a 6-MV 
photon beam for a total clinical target volume dose of  7300 
cGy and were completed in June 1992. She tolerated the 
treatments well and suffered no long-term neurological 
sequelae. She did not receive chemotherapy.
Between 1992 and 1997, the patient was monitored with 
regular clinical exams and cranial MRI scans. Her last 
MRI scan before her re-presentation, in January 1997, 
showed stable post-treatment changes. There was a small 
area with minimal high signal on FLAIR sequences with 
slight vasogenic edema on T2 weighted images, and mini-
mal post-contrast enhancement located adjacent to the 
surgical tract (Figure 1); this area was thought to be consis-
tent with a cortical venous structure, though tumor recur-
rence was not entirely excluded.
As she was not experiencing symptoms at the time of  her 
last visit in 1997, the patient elected not to follow-up until 
early 2006, when she began experiencing right-sided head-
aches of  moderate severity and occasional dizziness. The 
patient was neurologically intact on physical examination. 
MRI revealed a large multi-lobulated, partially cystic lesion 
within the left occipito-parietal region with extensive sur-
rounding vasogenic edema on T2 weighted images and 
mass effect on the posterior aspect of  the left lateral ventri-
cle with minimal midline shift (Figure 2). The solid, en-
hancing portion of  the lesion measured 2.2cm in greatest 
dimension, while the entire lesion measured 5.7cm. The 
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Radiation necrosis is a known sequela of  delivering high doses of  ionizing radiation to the central nerv-
ous system and may be confused with tumor recurrence. Although stereotactic radiation has found in-
creasing application in managing central nervous system malignancies, the imaging appearance of  be-
nign tissue several years after such treatment has not been frequently documented in the medical litera-
ture. We present the imaging and pathologic features of  brain tissue that received fractionated stereotac-
tic radiation by linear accelerator fourteen years earlier.
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lesion's cystic components displayed rim enhancement and 
there was increased cerebral blood volume versus the sur-
rounding brain. No generalized "Swiss cheese" or more 
isolated "soap bubble" pattern typical of  radiation necrosis 
was identified (1). Together, these findings of  new mass 
effect with midline shift, conspicuous increase of  vasogenic 
edema, and interval development of  an enhancing solid 
lesion with increased blood volume compared with normal 
tissue were considered to be highly suggestive for tumor 
recurrence (1, 2).
Resection was undertaken in March 2006. Observed at 
surgery, the lesion was red in appearance and expressed 
xanthochromatic fluid when surgically violated. Frozen 
sections revealed the presence of  necrosis and gliosis. Final 
pathology confirmed the presence of  necrosis and gliosis, 
but no tumor was identified within the resected specimen. 
The patient returned home, neurologically intact, four days 
after her surgery, and recovered uneventfully.
Discussion
Cerebral radiation necrosis, an expected late tissue toxic-
ity associated with radiation therapy, has been described as 
Radiation Necrosis Masquerading as Late Tumor Recurrence
RCR Radiology Case Reports | radiology.casereports.net 66  2007:2(2):65-68
Figure 1. Radiation necrosis masquerading as late tumor 
recurrence. Five years after treatment for malignant epen-
dymoma, A. Axial FLAIR MRI image showed stable post-
treatment changes and no residual or recurrent tumor. 
B. Axial FLAIR T2-weighted MRI image showed stable 
post-treatment changes and no residual or recurrent tumor. 
C. Axial post-gadolinium T1-weighted MRI image showed 
stable post-treatment changes and no residual or recurrent 
tumor.
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presenting between three months and 47 years after radia-
tion treatment (3, 5). Historically, the incidence of  radiation 
necrosis has varied from 5% to 24% in patients being 
treated with radiation for malignant gliomas (3, 4, 6). This 
wide range among studies has been attributed to different 
dose and fractionation regimens, improved imaging tech-
niques in modern series, and variable vigilance for this 
complication across studies (3). Factors influencing the like-
lihood of  developing cerebral radiation necrosis include: 
total dose, the volume irradiated, radiation fraction size, 
addition of  concurrent chemotherapy, survival time of  the 
patient, age of  the patient at time of  treatment, biologic 
equivalent dose (BED in Gy2), and the product of  dose and 
fraction size (Gy2)(1, 3, 6). A recent retrospective study by 
Ruben et al. looked at radiation necrosis incidence for 352 
patients that received a BED greater than or equal to 
85.5Gy2 (equivalent to 45Gy in 25 fractions using an 
alpha/beta ratio of  2 for brain tissue) for treatment of  
gliomas (6). This group identified a mean interval of  11.6 
months from the end of  radiation to the identification of  
necrosis and a greater than four-fold increase in risk of  ne-
crosis with the use of  concurrent chemotherapy (6). The 
Radiation Necrosis Masquerading as Late Tumor Recurrence
RCR Radiology Case Reports | radiology.casereports.net 67  2007:2(2):65-68
Figure 2A. Fourteen years after treatment for ma-
lignant ependymoma, axial FLAIR MRI image showed de-
velopment of a partially cystic lesion within the left occipital-
parietal region with extensive edema, mass effect on the left 
lateral ventricle, and midline shift. 
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Figure 2B. Fourteen years after treatment for malignant 
ependymoma, axial T2-weighted MRI showed development 
of a partially cystic lesion within the left occipital-parietal 
region with extensive edema, mass effect on the left lateral 
ventricle, and midline shift.
Figure 2C. Fourteen years after treatment for malignant 
ependymoma, axial post-gadolinium FLAIR MRI image 
showed a new multi-cystic lesion with a prominent solid 
component displaying marked contrast enhancement.
total dose of  radiation was the most important factor for 
development of  subsequent necrosis, and no instances of  
radiation necrosis were identified at a BED less than 
96Gy2. The patient in our case received a BED of  180Gy2.
Differentiating tumor recurrence from radiation-induced 
necrosis after high dose radiation therapy for a brain tumor 
by imaging can be challenging. This difficulty may be com-
pounded in patients that have undergone radiation dose 
escalation by stereotactic techniques since the long-term 
appearance and evolution of  damage to normal intracra-
nial tissues thus treated has been incompletely character-
ized in the published literature. Diffuse radiation necrosis 
after conventional radiation techniques typically gives areas 
of  increased signal intensity on T2-weighted and FLAIR 
sequences, often in a periventricular distribution (3). There 
is debate as to which, if  any, individual conventional MRI 
features are most consistent with necrosis. Kumar et al. 
identified both a diffuse "Swiss cheese" and the more iso-
lated "soap bubble" patterns as characteristic of  necrosis 
(1), while Mullins et al. (looking at patients treated with 
proton beams) found that individual imaging features were 
unable to reliably differentiate tumor recurrence from ne-
crosis (4). Rather, Mullins et al. showed that combinations 
of  findings may be most useful in identifying progressive 
glioma (e.g. corpus callosum involvement with multiple 
enhancing foci) (4). Perfusion-sensitive MRI allows for non-
invasive evaluation of  the passage of  blood through the 
brain's vasculature by measuring cerebral blood volume, 
blood flow, and/or mean transit time; a significant increase 
in perfusion relative to normal tissue is considered highly 
suggestive of  malignancy (3).
As shown in our case, MRI findings normally suggestive 
of  recurrent disease such as new mass effect with midline 
shift, conspicuous increase in vasogenic edema, increase in 
cerebral blood volume versus the surrounding brain, and 
development of  an enhancing solid lesion may be mislead-
ing (2, 3). We recommend a continued vigilant approach to 
the follow-up of  patients treated with stereotactic radiation 
therapy with the awareness that the radiographic appear-
ance within the high dose regions can be protean. Research 
into more accurate delineation of  tumor recurrence from 
benign tissue damage after conformal application of  high 
doses of  radiation is ongoing (3, 4).
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Figure 2D. Fourteen years after treatment for malignant 
ependymoma, axial MRI perfusion image showed increased 
cerebral blood volume suspicious for neoplasm. L32 corre-
sponds to the area of abnormality and L33 is normal brain. 
(Red denotes high cerebral blood volume; blue, low cere-
bral blood volume.)
